Training activity information
Details
Critically appraise and present new bioinformatics methods and assess clinical use in solid tumours
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Impact on service delivery
- Integration with existing systems
- Literature and evidence base
- New laboratory technologies
- Advances in methodologies and algorithms
- Service improvement
- Improvements to patient care
- Evaluation of developments
- Standards of care and guidelines
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- What new bioinformatics methods will you be appraising? What aspects of their clinical use in solid tumours will you assess?
- How will you develop your skills in critically evaluating new bioinformatics methods? What will you learn about the challenges and opportunities of applying these methods in a clinical setting for solid tumours?
- Will you research new bioinformatics methods relevant to solid tumours? Will you consider how these methods could be applied clinically? Have you discussed potential methods to appraise with your training officer?
In action
- Which new bioinformatics methods are you critically appraising? What criteria are you using for the appraisal? How are you assessing their potential clinical use in solid tumours? How are you structuring your presentation?
- Are you able to identify the key strengths and limitations of the new methods? Are you developing a clear understanding of their potential clinical applications and challenges in solid tumours? Is your presentation effectively conveying
- If you find conflicting information about the methods, how are you evaluating it? Are you adjusting your presentation based on the assumed knowledge of your audience? Are you prepared to discuss potential ethical or practical implications specific to solid tumours?
On action
- Describe the new bioinformatics method(s) you critically appraised. What were the key aspects of their methodology and potential clinical applications in solid tumours? Summarise your critical appraisal and your assessment of their clinical use.
- What criteria did you use to critically appraise the new methods (e.g., novelty, validity, feasibility, impact)? What factors did you consider when assessing their potential clinical use in the context of solid tumours? Were there any unexpected strengths or limitations of the methods you identified? What did you learn from these? How did your analytical and presentation skills (‘reflect-in-action’) shape your appraisal and assessment? How does the ability to critically appraise new methods relate to the advancement and adoption of innovative bioinformatics approaches in clinical practice, specifically in solid tumours?
- What aspects of critical appraisal of scientific methods do you want to develop further? How can you effectively communicate your appraisal and assessment to different audiences? What specific actions / ‘next steps’ will you now take to enhance your skills in this area? What support or resources might you need to further develop your expertise in evaluating bioinformatics methods relevant to solid tumour genomics?
Beyond action
- Have you encountered new bioinformatics methods relevant to the analysis of solid tumours since completing this training activity? How did your previous critical appraisal experience aid your understanding?
- Did the specific challenges of assessing clinical utility in solid tumours that you encountered in this training activity influence your thinking about other clinical applications of bioinformatics?
- Have you compared the bioinformatics approaches used in rare diseases, haematological oncology, and solid tumours? How did your experiences with these contribute to this comparative understanding?
- Are you more attuned to the specific bioinformatics needs and challenges associated with solid tumour analysis? Has your ability to assess the clinical utility of bioinformatics methods in a complex disease area been enhanced by this training activity? Have the presentation skills you developed been applicable to discussing bioinformatics in the context of solid tumour diagnostics or research with clinical teams?
- How might your knowledge of bioinformatics methods for solid tumours be relevant to future collaborations with oncology specialists or involvement in cancer-related research? In what ways will your experience in critically appraising and presenting in this context support your role in the implementation of new bioinformatics tools in a clinical setting? What further learning or engagement with the field of solid tumour bioinformatics would you find beneficial?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 5 |
Outcome
Critically appraise new technologies and methods objectively. |
| # 7 |
Outcome
Practice in accordance with relevant standards and guidance. |